Group Leader Position at the Institute of Oncology Research

The Institute of Oncology Research (IOR) in Bellinzona, Switzerland, is a rapidly evolving, leading center for basic and translational research in oncology in Europe. The aim of our research is to decode the mechanisms of cancer pathogenesis and develop innovative and rational-based avenues to fight cancer. Currently, the Institute hosts seven research groups working on lymphomas, hematopoietic ma...
More

Open positions for PhD student, PostDoc, Technician

Open positions in the Cancer Immunotherapy group directed by Dr. Arianna Calcinotto at the Institute of Oncology Research in Bellinzona, Switzerland Who we are: The Calcinotto lab is embedded in a large and vibrant immunology community in the sunny part of Switzerland at the international Institute of Oncology Research (IOR) that is affiliated with Università della Svizzera Italiana (USI). In...
More

Prestigious professorship awarded at the Institute of Oncology Research in Bellinzona

Stiftung Experimentelle Biomedizin has awarded Dr Arianna Calcinotto, Group Leader at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana) the Peter Hans Hofschneider Professorship 2020/2021. This is the third time the Zurich-based foundation has conferred the award in Switzerland. Arianna Calcinotto, who since 2019 heads the Cancer Immunotherapy resear...
More

IOR study reveals how breast cancer therapy may be effective against COVID-19

The so-called “Selective Estrogen Receptor Modulators (SERMs)” treatments used in breast cancer therapy may be effective against COVID-19. A study conducted by the Institute of Oncology Research (IOR, affiliated to USI) based on data obtained from the Veneto Tumor Registry (Italy) has observed a lower risk of developing the coronavirus disease for women affected by hormonal-driven cancers subje...
More

Why Specific Genetic Alterations Matter in Prostate Cancer

A given substance may be fundamental for life or may serve as a poison. All depends on the specific dose. At first glance, this somewhat paradoxical principle in medicine was first coined by the Swiss physician Paracelsus more than half a millennium ago when he stated: “All things are poison, and nothing is without poison. Solely the dose determines that a thing is not a poison”. Centuries later, ...
More

Circulating plasma extracellular vesicles give new insights for monitoring and managing disease progression in prostate cancer patients

The Prostate Cancer Biology group, led by Dr. Giuseppina Carbone, of the Institute of Oncology Research has discovered in circulating plasma extracellular vesicles a novel biomarker that is associated with aggressive prostate cancer. The study by Albino et al. is published in Communications Biology and is available at https://doi.org/10.1038/s42003-020-01642-5. The work is a collaborative effort ...
More